Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 03, 2024 08:00 ET | Source: iCAD, Inc.

iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024

NASHUA, N.H. and PARIS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, today...
September 11, 2024 08:00 ET | Source: iCAD, Inc.

iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024

NASHUA, N.H., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically...
August 13, 2024 16:01 ET | Source: iCAD, Inc.

iCAD Reports Financial Results for Second Quarter Ended June 30, 2024

NASHUA, N.H., Aug. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically...
August 06, 2024 08:00 ET | Source: iCAD, Inc.

iCAD to Report Second Quarter 2024 Financial Results on August 13, 2024

NASHUA, N.H., Aug. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial...
July 29, 2024 08:00 ET | Source: iCAD, Inc.

iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography

NASHUA, N.H. and WILLIAMSVILLE, N.Y. and RALEIGH, N.C., July 29, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today...
June 26, 2024 08:00 ET | Source: iCAD, Inc.

iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024

NASHUA, N.H., June 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, today announced it will highlight new research...
June 04, 2024 08:00 ET | Source: iCAD, Inc.

iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference

NASHUA, N.H., June 04, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast...
May 15, 2024 08:00 ET | Source: iCAD, Inc.

iCAD Reports Financial Results for First Quarter Ended March 31, 2024

NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast...
May 08, 2024 09:49 ET | Source: iCAD, Inc.

UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

NASHUA, N.H., May 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial...
May 02, 2024 08:00 ET | Source: iCAD, Inc.

iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

NASHUA, N.H., May 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial...